Tempus revenue up 36% to $348M; net loss doubles amid new privacy lawsuit, patent setback

Filed May 5, 2026 · Period ending March 31, 2026 · Compared to 10-Q May 6, 2025 · ~1 min read

Key Changes

• high

  Q1 2026 revenue grew 36% YoY to $348M, but net loss nearly doubled to $126M from $68M prior year, driven by stock-based comp jumping from $23M to $53M and higher R&D spend. Adjusted EBITDA improved to negative $2.8M, nearing breakeven.

  MD&A: Financial Results verify on EDGAR →
• high

  New class-action lawsuit filed in Illinois federal court alleging violations of state genetic privacy laws. Company states claims are without merit but faces significant defense costs and potential settlement exposure.

  Legal Proceedings verify on EDGAR →
• high

  Guardant filed second patent complaint targeting Tempus's xM tests, consolidated with existing Delaware case. Tempus's counter-complaint was dismissed with prejudice, eliminating offensive claims while Guardant's remain active.

  Legal Proceedings: Patent Litigation verify on EDGAR →